Single cell genomics completes the triumvirate of hot trends in genomics (the other two being liquid biopsies and spatial genomics). All three are driving a tremendous amount of demand for sequencing. There is a fairly broad range of companies that consider themselves to be “single cell”. Some focus solely on isolation of single (often rare)...
One of the hottest trends in NGS applications is that of spatial genomics - measuring nucleic acids and proteins while maintaining the XY (and sometimes Z) coordinates within the tissue sample. This is a very dynamic market with a variety of approaches with a lot of variability in terms of resolution, sampling method (explained below),...
Currently one of the most popular topics for my consultation calls is about the liquid biopsy market. The companies listed below are either offering or developing non-invasive (no solid tissue biopsies) diagnostic and screening methods. While “liquid biopsy” usually means “high complexity NGS cancer test from a blood sample” to most people, there are actually...
Sequencing Platform Companies Although Illumina is dominating next gen sequencing, there are several other sequencing platform companies on the market and several more with platforms in development (a trend that is likely to accelerate over the next few years). There is also a growing list of “former sequencing companies” in the NGS Necropolis. These lists...
Starting around six months ago, during the height of the bitcoin craze, a new segment in the genomics landscape started forming – “blockchain genomics”. Since then at least 10 companies in this space have formed. While they don’t all share the exact same business model, they’re all centered around the idea of aggregating consumer genomics...